Skip to content

Nephrectomy versus no nephrectomy for metastatic renal carcinoma

Nephrectomy versus no nephrectomy for metastatic renal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75184582
Enrollment
120
Registered
2001-02-28
Start date
1995-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cancer Cancer Renal

Interventions

1. One group receives a nephrectomy 2. The other receives no nephrectomy

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient should have locally operable disease and should be fit enough for nephrectomy 2. A renal tumour with clinical or radiological evidence of metastases 3. No previous malignancy (except non-melanotic skin cancer or in situ carcinoma of the cervix) 4. Written informed consent of the patient

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Time to progression 2. Metastase rate 3. Quality of life 4. Survival time

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026